Nutra Pharma Corp (NPHC) Change in Accured Expenses (2012 - 2026)

Nutra Pharma has disclosed Change in Accured Expenses across 15 years of filings, most recently posting $76000.0 for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 81.97% year-over-year to $76000.0; the TTM figure through Jun 2026 stood at $249005.0 (up 5.49% YoY), while the FY2025 annual figure was $213248.0, down 20.39% from the prior year.
• Change in Accured Expenses came in at $76000.0 for Q2 2026 at Nutra Pharma, up from $59048.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $706557.0 in Q4 2022 to a low of $40000.0 in Q1 2022.
• Average Change in Accured Expenses over 5 years is $92510.2, with a median of $58287.5 recorded in 2025.
• Year-over-year, Change in Accured Expenses surged 1735.21% in 2022 and plunged 89.22% in 2023.
• Over 5 years, Change in Accured Expenses stood at $706557.0 in 2022, then sank by 89.22% to $76185.0 in 2023, then slipped by 20.24% to $60764.0 in 2024, then climbed by 0.12% to $60837.0 in 2025, then grew by 24.92% to $76000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $76000.0 in Q2 2026, $59048.0 in Q1 2026, and $60837.0 in Q4 2025.